BioCentury
ARTICLE | Company News

Evotec, Haplogen in discovery deal for infectious diseases

November 16, 2012 1:52 AM UTC

Evotec AG (Xetra:EVT) and Haplogen GmbH (Vienna, Austria) partnered to discover and develop small molecules against an undisclosed protein to treat viral infectious diseases. The protein was identifie...